Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

30.97
-0.2900-0.93%
Post-market: 31.060.0900+0.29%16:42 EDT
Volume:5.76M
Turnover:180.63M
Market Cap:11.98B
PE:-3.55
High:32.07
Open:31.53
Low:30.88
Close:31.26
Loading ...

How Moderna Went From Pandemic Hero to Vaccine Victim -- WSJ

Dow Jones
·
03 Jun

Moderna caught up in government changes to vaccine rules, WSJ says

TIPRANKS
·
03 Jun

Post-Bell | U.S. Stocks Close Higher; Tesla Drops 1%; Nvidia Gains 2%; Cleveland-Cliffs Surges 23%; Applied Digital Soars 48%

Tiger Newspress
·
03 Jun

Moderna Shares up 1.9% After U.S. FDA Approves Co's Next-Generation Covid Vaccine for Adults Aged 65 or Older

THOMSON REUTERS
·
02 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing

Reuters
·
02 Jun

Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA)

TIPRANKS
·
02 Jun

Moderna Surges over 5% on FDA Approval of Next-Gen Covid Vaccine for Seniors

Stock Track
·
02 Jun

Stock Track | Moderna Soars 5% Pre-market on FDA Approval of Next-Gen Covid Vaccine for Older Adults

Stock Track
·
02 Jun

Moderna Shares up 4.3% Premarket After U.S. FDA Approves Co's Next-Generation Covid Vaccine for Adults Aged 65 or Older

THOMSON REUTERS
·
02 Jun

Barclays Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
02 Jun

Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (OtherCHJTF) and Moderna (MRNA)

TIPRANKS
·
02 Jun

US FDA Approves Moderna's Next-Generation COVID Vaccine for Adults 65 or Older

Reuters
·
31 May

Moderna - Expects to Have Mnexspike Available for Eligible Populations in the U.S. for the 2025-2026 Respiratory Virus Season

THOMSON REUTERS
·
31 May

Moderna Receives U.S. FDA Approval for Covid-19 Vaccine Mnexspike

THOMSON REUTERS
·
31 May

US CDC keeps recommendation of COVID vaccines for healthy kids, report says

Reuters
·
31 May

U.S. Cdc Keeps Covid Vaccine Recommendation for Kids, Contradicting Health Secretary -Washington Post

THOMSON REUTERS
·
31 May

PRESS DIGEST- New York Times business news - May 30

Reuters
·
30 May

Moderna Inc. Stock Climbs 3.4%, Outperforms Competitors

Dow Jones
·
30 May

HHS to cancel nearly $600M Moderna flu vaccine contract, STAT reports

TIPRANKS
·
29 May

Moderna Announces Positive Interim Results from Phase 1/2 Clinical Study of H5 Avian Flu Vaccine

Reuters
·
29 May